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Executive Summary 
This research project was designed to provide a summary of the studies related to 
adult ADHD and smoking, and utilize these findings to improve future research about 
adult ADHD and smoking in Northwestern Ontario. The project is split into three main 
sections: 1) The Epidemiology of ADHD, Smoking, and Substance Abuse Among the 
United States, Canada, Ontario and Thunder Bay; 2) Adult ADHD & Smoking: A 
Review of the Literature; and, 3) Paving the Way for Research in ADHD and Smoking in 
NW Ontario. A literature review was conducted for each particular section including a 
search of relevant English databases as well as the grey literature. A more detailed 
explanation of the methods used can be found in the beginning of each section. 
Overview of Section 1: The Epidemiology of ADHD, Smoking, and Substance Abuse 
Among the United States, Canada, Ontario and Thunder Bay 
The section entitled “The Epidemiology of ADHD, Smoking, and Substance Abuse 
Among the United States, Canada, Ontario and Thunder Bay” provided prevalence rates 
for ADHD, smoking, and substance use/abuse, across different age groups, genders and 
geographical locations. This section yielded a number of important findings: 
the prevalence of ADHD tends to be higher in children than adults, males than 
females, and whites/non-hispanics than other ethnic backgrounds 
the prevalence of smoking tends to be highest in Thunder Bay compared to the 
United States, Canada, and Ontario 
smoking prevalence decreases with age and is higher among males than females 
individuals with ADHD smoke at a much higher rate than individuals without 
ADHD 
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individuals with ADHD are much more likely to develop some form of substance 
abuse/dependence, including alcohol abuse/dependence and illicit drug 
use/dependence 
Overview of Section 2: Adult ADHD & Smoking: A Review of the Literature 
The “Adult ADHD & Smoking: A Review of the Literature” section provides a 
summary of the studies related to adult ADHD and smoking. The findings showed that 
individuals with ADHD smoke at a greater rate and have a more difficult time quitting 
smoking than individuals without ADHD. In particular, the nicotine from the cigarettes 
helps to alleviate adult ADHD symptoms that, to this point, have not been equaled by any 
other treatment. 
Additionally, the adult ADHD & smoking review section explores some 
considerations relative to interventions for smokers with adult ADHD, as well as 
effective alternatives to nicotine for treating adult ADHD. This section emphasizes the 
need to understand the difference between a smoker with and without adult ADHD, and 
the potential risks involved when prescribing smoking cessation medication for smokers 
with adult ADHD. Also, it is noted that a great deal of research still needs to be done to 
establish the most effective method of treating adult ADHD. 
Overview of Section 3: Paving the Way for Research in ADHD and Smoking in NW 
Ontario 
The “Paving the Way for Research in ADHD and Smoking in NW Ontario” 
section provides a table summarizing the screening tools/rating scales used to measure 
adult ADHD, including psychometric properties and criticisms of the tools/scales. It was 
found that while the rating scales are a relatively inexpensive and effective way to 
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measure adult ADHD, they introduce problems of recall bias, self-reflection, and self- 
evaluation. 
This section also explores particular considerations of an adult ADHD and 
smoking study, a stimulant drug study in Northwestern Ontario, and an adult ADHD 
study in Northwestern Ontario. It was noted that a study about adult ADHD and smoking 
should include such topics as smoking history and habits, smoking motivation, history of 
stimulant medication, and history of substance use and abuse. This section concludes 
that a stimulant drug study is not worthwhile in Northwestern Ontario as the magnitude 
of the problem of ADHD & smoking in Northwestern Ontario is unknown at this time. 
Based on the high smoking rates in Northwestern Ontario and the high smoking rates of 
adults with ADHD, it is necessary to first determine the prevalence rate of adult ADHD 
in Northwestern Ontario. 
Conclusion 
It is clear that adults suffering from ADHD smoke at a higher rate than 
individuals without ADHD, and that the proper treatment for adult ADHD has not yet 
been established. With the high rates of smoking and the lack of adult ADHD research in 
Northwestern Ontario, it is necessary to establish an initial prevalence rate of adult 
ADHD in Northwestern Ontario. 
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Section 1: The Epidemiology of ADHD, Smoking, and Substance Abuse Among the 
United States, Canada, Ontario and Thunder Bay 
Introduction 
This section reports current epidemiological data relative to ADHD, smoking, and 
substance abuse. This section aims to answer six specific questions: 1) What is the 
prevalence of ADHD in Northwestern Ontario, Ontario, Canada, and the United States by 
age, gender, and race/ethnicity? 2) What is the prevalence of smoking in Northwestern 
Ontario, Ontario, Canada, and the United States by age and gender? 3) What is the 
prevalence of ADHD among smoking populations? 4) What is the prevalence of 
smoking among ADHD populations? 5) What is the prevalence of substance 
abuse/dependence in Ontario, Canada, and the United States by age and sex? 6) What is 
the relationship between substance use and abuse among ADHD populations? 
Method 
A literature review was done on the prevalence of ADHD, smoking, ADHD and 
smoking, substance use and abuse, and ADHD and substance use and abuse. The review 
included a search of English databases - Pubmed, ERIC, and the Cochrane Library. The 
grey literature search included professional associations and government websites - 
American Psychiatric Association, Centers for Disease Control and Prevention, Health 
Canada, and Statistics Canada, as well as google.ca and scholar.google.ca. Keywords for 
the search included ADHD, smoking, nicotine, tobacco use, substance 
use/abuse/disorder, prevalence, rate, national, adult, adolescent, youth and child. 
Searching was limited to 1995 to 2008. Most research published prior to 1995 would not 
be relevant to informing the current prevalence rates today, but needed to go back to 1995 
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due to the dearth of literature on ADHD and smoking, and ADHD and substance use and 
abuse. Subject/MESH headings or keywords, depending upon the database’s indexing 
system, were used to retrieve citations. 
Results 
Research Question 1: Prevalence Rates of ADHD 
This section explores the prevalence rates of Attention-Deficit Hyperactivity 
Disorder (ADHD) among children, youth and adults. The rates of ADHD in children, 
youth and adults are compared by age, gender and race/ethnicity. 
According to the American Psychiatric Association (2000), a clinical diagnosis of 
childhood ADHD requires six or more symptoms of either inattention of hyperactivity- 
impulsivity present for at least 6 months to a point that is disruptive and inappropriate for 
developmental level. A clinical diagnosis of adult ADHD requires six or more symptoms 
of either inattention of hyperactivity-impulsivity present for at least 6 months (criterion 
A), at least two criterion A symptoms before age 7 (criterion B), some impairment in at 
least two areas of living during the past 6 months (criterion C), and clinically significant 
impairment in at least one of these areas (criterion D; Kessler et al., 2006). 
The only nationally representative literature related to ADHD came from studies 
within the United States (Froehlich et al., 2007; Kessler et al., 2006). While ADHD rates 
have been noted in Canadian literature, none of the studies provided nationally 
representative data to properly compare to the United States data. Since ADHD rates in 
Canadian literature show a great deal of parity to ADHD rates in the United States 
literature, it was acceptable to only use the United States data in this section. 
Adult ADHD & Smoking in NW Ontario 11 
The ADHD prevalence rates presented in this section are adapted from two 
different sources. The child/youth ADHD prevalence rates were adapted from a 
nationally representative study by Froehlich et al. (2007). This study used a cross- 
sectional survey entitled: National Health and Nutrition Examination Survey, sampling 
3082 children between the ages of 8-15 years old (Froehlich et al., 2007). The adult 
ADHD prevalence rates were adapted from a nationally representative study by Kessler 
et al. (2006). This study included a screen for adult ADHD in a probability subsample 
(N=3,199) of 18-44 year old respondents in the National Comorbidity Survey Replication 
(Kessler et al., 2006). While the two studies vary slightly in methodology, they are each 
based on current, nationally representative ADHD data in the United States. 
Prevalence of Child/Youth ADHD. The overall ADHD prevalence among 
children & youth aged 8-15 years is 8.7% (Froelich et al., 2007; Table 1). 
Prevalence of Child/Youth ADHD by Age. There were two age categories 
sampled among children and youth for the prevalence of ADHD: 8-11 years of age and 
12-15 years of age. Individuals 8-11 years of age had higher rates of ADHD than 
individuals 12-15 years of age (10% vs. 7.5%, respectively; Froelich et al., 2007; Table 
1 \ 
Prevalence of Child/Youth ADHD by Gender. The prevalence of ADHD was 
more than double for males compared to females (11.8% vs. 5.4%, respectively) among 
those aged 8-15 years (Froelich et al., 2007; Table I). 
Prevalence of Child/Youth ADHD by Race/Ethnicity. ADHD rates were higher in 
non-Hispanic white children (9.8%) than African American children (8.7%), Mexican 
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American children (6.0%) and children of “other race/ethnicity” (5.2%; Froelich et al., 
2007; Table 1). 
Table 1: Child/Youth ADHD Prevalence (2007)  
Characteristic Percentage (%) 95% Cl* 
Age 
8-11 years 10 (8-12) 
12-15 years 7.5 (6-9) 
Gender 
Male 11.8 (10-14) 
Female 5.4 (4-7) 
Race/Ethnicity 
White/Non-Hispanic 9.8 (7-12) 
African American 8.7 (6-11) 
Mexican American 6 (4-8) 
Other 5^2 (2-9) 
Children/Youth 8-15 Years (Total) 8Y (7-10) 
Adapted From: Froelich et al., 2007. 
* Denotes Confidence Interval (95%) 
Prevalence of Adult ADHD. The overall ADHD prevalence among adults aged 
18-44 years is 4.4% (Kessler et al., 2006; Table 2). An important limitation for 
determining rates of ADHD among adults is that the DSM-IV criteria for ADHD were 
developed with children in mind and offer only minimal guidance regarding diagnosis 
among adults (Kessler et al., 2006). According to Kessler et al. (2006), clinical studies 
make it clear that symptoms of ADHD are more heterogeneous and subtle in adults than 
children, leading some clinical researchers to suggest that assessment of adult ADHD 
requires an increase in the variety of symptoms assessed, a reduction in the severity 
threshold, or a reduction in the DSM-IV requirements for six of nine symptoms. To the 
extent that such changes would lead to a more valid assessment than in the current study, 
the prevalence estimates presented in Table 2 are conservative. 
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Prevalence of Adult ADHD by Age. There were three age categories sampled 
among adults for the prevalence of ADHD in the Kessler study: 18-24 years of age, 25- 
34 years of age, and 35-44 years of age. There were no data about the prevalence of 
ADHD for adults aged 45 years and older. Among the three sampled age categories, 
adults 35-44 years of age had the highest rate of ADHD (4.6%), followed by adults 18-24 
years of age (4.5%), and adults 25-34 years of age (3.8%; Kessler et al., 2006; Table 2). 
Prevalence of Adult ADHD by Gender. Rates of meeting DSM-IV criteria for 
ADHD were higher for males as opposed to females (5.4% vs. 3.2%, respectively) among 
those aged 18-44 years (Kessler et al., 2006; Table 2). 
Prevalence of ADHD by Race/Ethnicity. ADHD rates were higher in non- 
Hispanic white adults (5.4%) than non-Hispanic black adults (1.9%), Hispanic adults 
(2.1%), and adults of “other race/ethnicity” (3.6%; Kessler et al., 2006; Table 2). 
Table 2: Adult ADHD Prevalence (2006)  
Characteristic Percentage (%) SE* 
Age 
18-24 years 4.5 1 
25-34 years 3.8 0.8 
35-44 years 4.6 0.9 
Gender 
Male 5.4 0.9 
Female 3.2 0.6 
Race/Ethnicity 
Non-Hispanic White 5.4 0.8 
Non-Hispanic Black 1.9 0.6 
Hispanic 2.1 0.8 
Other T6 1.8 
Adults 18-44 Years (Total) A4 0.6 
Adapted From: Kessler et al., 2006. 
* Denotes Standard Error 
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Prevalence of Child/Youth ADHD vs. Adult ADHD. The prevalence of ADHD 
was higher among children and youth (8.7%) than among adults (4.4%) according to 
national data for the United States (Froelich et ah, 2007; Kessler et ah, 2006; Table 1, 
Table 2). 
Prevalence of Child/Youth ADHD V5. Adult ADHD by Age. The prevalence of 
ADHD is highest among young children and lowest among middle-aged adults, with 
rates of 10.0% for 8-11 year olds, 7.5% for 12-15 year olds, 4.5% for 18-24 year olds, 
3.8% for 25-34 year olds, and 4.6% for 35-44 year olds (Froelich et ah, 2007; Kessler et 
ah, 2006; Table 1, Table 2). 
Prevalence of Child/Youth ADHD vs. Adult ADHD by Gender. The prevalence 
of ADHD is higher for males than females among children, youth, and adults. While the 
rates are more than double for males compared to females among children and youth 
(11.8% and 5.4%, respectively), the gender difference is less pronounced among adults 
(5.4% and 3.2%, respectively; Froelich et ah, 2007; Kessler et ah, 2006; Table 1, Table 
Prevalence of Child/Youth ADHD vs. Adult ADHD by Race/Ethnicity. The 
prevalence rate of ADHD is highest among white, non-hispanic individuals compared to 
other racial/ethnic backgrounds, in both the child/youth population and the adult 
population (Froelich et ah, 2007; Kessler et ah, 2006; Table 1, Table 2). 
Research Question 2: Prevalence of Cigarette Smoking 
This section explores the prevalence rates of cigarette smoking in the United 
States, Canada, Ontario, and Thunder Bay. The rates of cigarette smoking are compared 
by age and gender among these four populations. 
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Cigarette smoking is defined differently between the United States and Canada. 
In the United States, “current cigarette smokers” are defined as ever smoking 100 
cigarettes in their lifetime and smoking now every day or on some days (Centers for 
Disease Control and Prevention [CDC], 2007a). In Canada, Ontario and Thunder Bay, 
“current smokers” include daily smokers and non-daily/occasional smokers, determined 
from the response to the question “At the present time do you smoke cigarettes every day, 
occasionally, or not at all?” (Health Canada, 2007; Statistics Canada, 2005). 
The cigarette smoking rates presented in this section are adapted from a variety of 
sources, including: Centers for Disease Control and Prevention (2007a); Health Canada 
(2007); and Statistics Canada (2005). While the different sources vary slightly in the 
methodology used to determine smoking prevalence, they are all based on nationally 
representative data in the United States and Canada. It should be noted that the data have 
been adapted to develop a clear picture of smoking prevalence rates by age and gender 
among the four populations. However, due to the different sources and adapted 
information used in this section, the figures should be interpreted with caution. 
Overall Smoking Prevalence. The overall smoking rates for the United States, 
Canada, Ontario, and Thunder Bay are 20.8%, 18.6%, 20.2%, and 25.5%, respectively 
(CDC, 2007a; Health Canada, 2007; Statistics Canada, 2005; Figure 1). 
Smoking Prevalence by Gender. A higher percentage of males versus females 
smoke according to national data for Canada (Health Canada, 2007) and the United States 
(CDC, 2007a), and provincial data for Ontario (Statistics Canada, 2005). The smoking 
rates for males are quite similar for the US, Canada, and Ontario, ranging from 20.8% to 
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23.4%, respectively, with rates being 4-5% higher than that reported for females (16.5% 
to 18.2%; Figure 1). 
Data for the Thunder Bay District Health Unit, however, show quite a different 
pattern—more females (30.2%) than males (20.8%) smoke, and the absolute smoking 
prevalence for Thunder Bay District females is 12-14% higher than that reported for their 
counterparts in the US, Canada, and Ontario, which ranged from 16.5% to 18.3% 
(Statistics Canada, 2005; Figure 1). 
Figure 1: Percentage of Smokers by Gender in United States, Canada, Ontario and 













United States (2007)a Canada (2007)b Ontario (2005)c Thunder Bay (2005)d 
Adapted From: 
“ Centers for Disease Control and Prevention, National Center for Health Statistics, 2007 
Canadian Tobacco Use Monitoring Survey, February - June, 2007 
‘^■‘‘Statistics Canada, Canadian Community Health Survey (CCHS 3.1), January - June, 2005 
* Thunder Bay District refers to the population of the city of Thunder Bay and surrounding area as sampled 
by the Thunder Bay District Health Unit 
Adult ADHD & Smoking in NW Ontario 17 
Smoking Prevalence by Age. According to United States and Canadian national 
data, Ontario provincial data, and Thunder Bay District Health Unit data, smoking rates 
are highest for young adults and lowest for older adults, ranging from 23.6% to 38.8% for 
20-34 year olds, 21.1% - 34.2% for 35-44 year olds, and 15.0% to 18.5% for 45+ years 
(CDC, 2007a; Health Canada, 2007; Statistics Canada, 2005). As with the overall 
prevalence rates, the smoking rates for Thunder Bay District Health Unit are higher at 
each age range than that for the United States, Canada, and Ontario, especially for adults 
20-34 years old and 35-44 years old, with rates for those 45+ years being relatively 
similar in Thunder Bay District to the rest of the province, country, and United States 
(Figure 2). 
Adult ADHD & Smoking in N W Ontario 18 
Figure 2: Percentage of Smokers by Age in United States, Canada, Ontario and Thunder 
Bay District* 
100% 
United States (2007)a 
Canada (2007)b 
Ontario (2005)c 











® Centers for Disease Control and Prevention, National Center for Health Statistics, 2007 
’’Canadian Tobacco Use Monitoring Survey, February - June, 2007 
Statistics Canada, Canadian Community Health Survey (CCHS 3.1), January - June, 2005 
* Thunder Bay District refers to the population of the city of Thunder Bay and surrounding area as sampled 
by the Thunder Bay District Health Unit 
Smoking Prevalence Among Males by Age. According to United States and 
Canadian national data and Ontario provincial data, smoking rates among males are 
highest for young adults and lowest for older adults, ranging from 26.5% to 31.6% for 
20-34 year olds, 23.5% - 27.5% for 35-44 year olds, and 15.4% to 19.1% for 45+ years 
(CDC, 2007a; Health Canada, 2007; Statistics Canada, 2005). Data for the Thunder Bay 
District Health Unit, however, show a different pattern—more 35-44 year old males 
smoke (34.8%) compared to 20-34 year old males (30.7%; Figure 3). 
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Figure 3: Percentage of Male Smokers by Age in United States, Canada, Ontario, and 




—■—United States (2007)a 
□ Canada (2007)b 
O Ontario (2005)c 











^ Centers for Disease Control and Prevention, National Center for Health Statistics, 2007 
'^Canadian Tobacco Use Monitoring Survey, February - June, 2007 
Statistics Canada, Canadian Community Health Survey (CCHS 3.1), January - June, 2005 
* Thunder Bay District refers to the population of the city of Thunder Bay and surrounding area as sampled 
by the Thunder Bay District Health Unit 
Smoking Prevalence Among Females by Age. According to United States and 
Canadian national data and Ontario provincial data, smoking rates among females are 
highest for young to middle-aged adults and lowest for older adults, ranging from 19.9% 
to 21.1% for 20-34 year olds, 18.7% - 25.4% for 35-44 year olds, and 13.6% to 15.7% for 
45+ years (CDC, 2007a; Health Canada, 2007; Statistics Canada, 2005). However, data 
from the Thunder Bay District Health Unit show a different pattern among females. The 
smoking rates are higher at each age range for Thunder Bay females than that for the 
United States, Canada, and Ontario. The 33.6% rate for 35-44 year old females in 
Thunder Bay is relatively close to the United States, Canada, and Ontario, which ranges 
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from 18.7% to 25.4%. In contrast, the 47.3% rate for 20-34 year old females in Thunder 
Bay is 26%-28% higher than the 19.9% to 21.1% range of the United States, Canada, and 
Ontario, while the 32.4% rate for 45+ years is 17% to 19% higher than the 13.6% to 
15.7% range of the United States, Canada, and Ontario (Figure 4). The elevated smoking 
rates of Thunder Bay females, particularly at the 20-34 year-old range and the 45 year- 
old plus range, likely contribute to Thunder Bay’s overall higher rate of smoking 
compared to the United States, Canada and Ontario. 
Figure 4: Percentage of Female Smokers by Age in United States, Canada, Ontario and 
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Centers for Disease Control and Prevention, National Center for Health Statistics, 2007 
‘’Canadian Tobacco Use Monitoring Survey, February - June, 2007 
‘^■‘‘Statistics Canada, Canadian Community Health Survey (CCHS 3.1), January - June, 2005 
* Thunder Bay District refers to the population of the city of Thunder Bay and surrounding area as sampled 
by the Thunder Bay District Health Unit 
Research Question 3: Prevalence of ADHD Among Smoking Populations 
There was no literature on ADHD prevalence among smoking populations. 
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Research Question 4: Prevalence of Smoking Among ADHD Populations 
The majority of literature on smoking prevalence and ADHD came from studies 
within the United States. However, there have been very few studies that have 
specifically looked at the relationship between smoking prevalence and ADHD. In fact, 
many studies of ADHD have examined the elevated prevalence of substance use 
disorders (SUD’s), often grouping smoking into the category of SUD’s. As a result, there 
are few studies that examine the prevalence of smoking among ADHD populations and 
no studies at all that examine the prevalence of ADHD among smoking populations. 
Prevalence of Smoking Among ADHD Populations: Adolescents vs. Adults. 
According to a nationally representative study by Fuemmeler et al. (2007), the prevalence 
of smoking is higher among ADHD adults than ADHD adolescents. However, the 
prevalence rates of smoking between these two populations have varied in terms of 
consistency. The smoking rates among adolescents with ADHD vary considerably, while 
the smoking rates among adults with ADHD are quite consistent. This finding is noted 
by Fuemmeler et al. (2007), who summarized a number of studies and reported rates of 
smoking among ADHD adolescents (19.0-46% vs. 10-24% for ADHD and non-ADHD, 
respectively), and among ADHD adults (41-42% vs. 26% for ADHD and non-ADHD, 
respectively). 
Smoking Prevalence Across the Lifespan Among ADHD Populations. The first 
group to really examine the relationship between smoking prevalence and ADHD over 
the lifespan was Lambert and Hartsough (1998). Four of their key findings were: 1) 
Individuals with ADHD initiate and begin regular smoking at an earlier age than 
individuals without ADHD; 2) In childhood and adolescence, individuals with ADHD are 
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two times as likely to have smoked cigarettes daily compared to individuals without 
ADHD; 3) In adulthood, there is a greater prevalence of smoking among individuals with 
ADHD (42%) compared to individuals without ADHD (26%); and, 4) Individuals with 
ADHD have twice the lifetime tobacco dependency rates of individuals without ADHD. 
Smoking Prevalence Among ADHD and Non-ADHD Adults. The most important 
finding from the Lambert and Hartsough (1998) study is that 42% of adults with ADHD 
smoke compared to 26% of adults without ADHD. This finding replicated earlier results 
published by Pomerleau et al. (1995), who established that adults with ADHD have 
higher rates of nicotine dependence than the general population (40% vs. 26%, 
respectively). The rates produced by Pomerleau et al. (1995) and Lambert & Hartsough 
(1998) have remained consistent over time and are often cited in studies examining adult 
ADHD and smoking. 
Research Question 5: Prevalence of Substance Use & Dependence 
This section explores the prevalence rates of substance use and dependence (other 
than tobacco) in the United States, Canada, and Ontario. The substance use and 
dependence rates were unavailable for Thunder Bay. The rates of substance use and 
dependence are compared by age and gender among these populations. 
Alcohol dependence is measured differently between the United States and 
Canada. In the United States, “heavy alcohol use” is defined as drinking five or more 
drinks on the same occasion on each of five or more days in the past 30 days (CDC, 
2007b). In Canada and Ontario, individuals who reported having had five drinks or more 
on one occasion at least once during the previous 12 months, and those who reported 
having had five drinks or more during another 12 month period in their lives were 
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administered “alcohol dependence” questions. Respondents who endorsed three (or 
more) of seven symptoms, within 12 months prior to the interview, were classified as 
displaying “alcohol dependence”. The seven symptoms include: being drunk at 
work/school, or while taking care of a child; tolerance (need for markedly increased 
amounts of alcohol to achieve desired effect); withdrawal; drinking larger amounts than 
was intended; spending a great deal of time in activities necessary to obtain, use, or 
recover from effects of drinking; giving up social, occupational, or recreational activities 
because of drinking; and continued drinking despite knowledge of having physical or 
psychological problem that is likely to have been caused or exacerbated by alcohol 
(Statistics Canada, 2004). 
The substance use and dependence rates presented in this section are adapted from 
a variety of sources, including: CDC, 2007b; Gadalla and Piran, 2007; and Statistics 
Canada, 2004. While the different sources vary slightly in the methodology used to 
determine rates of substance use and dependence, they are all based on current, nationally 
representative data in the United States and Canada. It should be noted that the data have 
been adapted to develop a clear picture of substance use and dependence rates by age and 
gender among the populations. Thus, due to the different sources and adapted 
information used in this section, the figures should be interpreted with caution. 
Prevalence of Alcohol Dependence. Alcohol dependence was highest overall 
among the United States (6.6%), followed by Ontario (6.0%), and Canada (2.6%; CDC 
2007b; Statistics Canada, 2004; Figure 5). 
Alcohol Dependence by Sex. Alcohol dependence was approximately three times 
higher among males than females in the United States (10.3% and 3.1%, respectively). 
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Ontario (9.0% and 3.0%, respectively), and Canada (3.8% and 1.3%, respectively; CDC, 
2007b; Statistics Canada, 2004; Figure 5). 
Figure 5: Percentage of Alcohol Dependence by Sex in United States, Canada and 
Ontario 
Adapted From: 
® Substance Abuse and Mental Health Services Administration, Office of Applied Studies, National Survey 
on Drug Use & Health, 2007 
Statistics Canada, Canadian Community Health Survey, Mental Health and Well-being, 2002 (updated in 
September 2004) 
Prevalence of Drug Use and Dependence. Drug use and dependence are 
measured differently between the United States and Canada. According to the Centers 
for Disease Control and Prevention (2007), any illicit drug includes marijuana/hashish, 
cocaine (including crack), heroin, hallucinogens (including LSD and PCP), inhalants, or 
any prescription-type psychotherapeutic drug used nonmedically. According to Statistics 
Canada (2004), there are two different measures of drug use in Canada (cannabis drug 
use and illicit drug use) and one measure of drug dependence in Canada (illicit drug 
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dependence). Cannabis drug use indicates whether respondents use marijuana, cannabis 
or hashish in their lifetime and in the past year, excluding one time use in a lifetime 
(Statistics Canada, 2004). Illicit drug use indicates whether respondents use 
marijuana/cannabis/hashish, cocaine/crack, glue/gasoline/other solvents, amphetamines 
(speed), MDMA (ecstasy), hallucinogens/PCP/LSD, heroin, or steroids (lifetime as well 
as in the past year). Illicit drug dependence assessed whether the respondent met the 
criteria for illicit drug dependence in the year prior to the interview. Respondents were 
classified as “drug dependent” if they reported three (or more) of six symptoms, all 
exhibited within the same 12 month period. The six symptoms include: tolerance; 
withdrawal; taking larger amounts than was intended; spending a great deal of time in 
activities necessary to obtain, use, or recover from the drug effects; reduced important 
activities because of drug use; and continued drug use despite knowledge of having 
physical or psychological problem that is likely to have been caused or exacerbated by 
the drug (Statistics Canada, 2004). 
Illicit Drug Use in United States. Rates of substance use in the United States are 
derived from the Centers for Disease Control and Prevention (CDC, 2007). The overall 
prevalence of any past month illicit drug use in the United States is 8.1% (CDC, 2007b; 
Figure 6). 
Illicit Drug Use in United States by Age. Illicit drug use prevalence was highest 
among young adults and lowest among young children and middle to older age adults, 
with rates of 3.8% for 12-13 years old, 8.9% for 14-15 years old, 17.0% for 16-17 years 
old, 20.1% for 18-25 years old, 11.0% for 26-34 years old, and 4.5% for 35+ years (CDC, 
2007b; Figure 6). 
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Adapted From: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 
National Survey on Drug Use & Health, 2007 
Drug Use and Dependence in Canada. Rates of substance use in Canada are 
derived from the Canadian Community Health Survey [CCHS] (Statistics Canada, 2004). 
The CCHS is a nationally representative survey of individuals aged 15 years and older in 
Canada. 
According to Statistics Canada (as cited in Gadalla & Piran, 2007), rates of illicit 
drug use are higher than rates of cannabis drug use for both lifetime and past year use 
(Figure 7). 
Drug Use and Dependence in Canada by Sex. Reported substance use rates were 
higher for males than females among lifetime and 12 month use of illicit drugs and 
cannabis, as well as illicit drug dependence (Statistics Canada, as cited in Gadalla & 
Piran, 2007). Rates of lifetime use of illicit drugs and cannabis for males (39.3% and 
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37.5%, respectively) were 11-12% higher than females (27.9% and 26.8%, respectively), 
and rates of past year use of illicit drugs and cannabis for males (15.2% and 14.5%, 
respectively) were 6-7% higher than females (8.6% and 8.2%, respectively). Also, 
reported rates of illicit drug dependence were more than double among males (1.1%) than 
females (0.5%; Gadalla & Piran, 2007; Figure 7). 
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2007 
Research Question 6: Substance Use and Abuse Among ADHD Populations 
This section explores substance use and abuse among children and adults 
diagnosed with ADHD. The relationship between substance use and abuse and ADHD is 
discussed among children, while prevalence rates between substance use disorder and 
ADHD are explored among adults. 
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Substance Use Among Children and Adolescents With ADHD 
According to Wilson and Levin (2005), ADHD is a major risk factor for the 
development of substance use disorder (SUD). In fact, children with ADHD are four 
times more likely to develop SUD by adulthood compared to children without ADHD. 
ADHD alone does not appear to increase the rates of substance use and abuse 
among children. In a recent study by Barkley et al. (2004), children with ADHD did not 
differ on any types of drug or alcohol use compared to children without ADHD. 
However, when ADHD and conduct disorder were combined, the reported rates of 
marijuana and alcohol use increased significantly among children compared to the 
ADHD only group (Barkley et al., 2004). Marijuana was used an average of 89 times 
over three months among the ADHD only group, while it was used an average of 510 
times over three months among the ADHD and conduct disorder group (Barkley et al., 
2004). Also, individuals in the ADHD group reported an average of 6.8 alcoholic drinks 
per week, while the individuals in the ADHD and conduct disorder group reported an 
average of 15.4 drinks per week (Barkely et al., 2004). A similar finding was noted by 
Wilson and Levin (2005), who found that the presence of both ADHD and conduct 
disorder increased the risk for SUD in children. 
Substance Use Among Adults With ADHD. According to nationally 
representative data presented by Kessler et al. (2006), adults with ADHD have an 
elevated prevalence of substance use disorders. In fact, nearly three times as many adults 
with ADHD (15.2%) have a substance use disorder compared to adults without ADHD 
(5.6%; Table 3). Substance use disorders were assessed in the survey by using the World 
Health Organization (WHO) Composite International Diagnostic Interview (CIDI) 
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version 3.0 (Kessler et al., 2006). The substance abuse section of the CIDI includes 
alcohol abuse, alcohol dependence, drug abuse and drug dependence (Kessler & Ustun, 
2004). 
Alcohol Use Among Adults with ADHD. The prevalence of alcohol abuse and 
alcohol dependence was more than double among adults with ADHD (5.9% and 5.8%, 
respectively), compared to adults without ADHD (2.4% and 2.0%, respectively; Kessler 
et al., 2006; Table 3). 
Drug Use Among Adults with ADHD. The prevalence of drug abuse and drug 
dependence was higher among adults with ADHD (2.4% and 4.4%, respectively), 
compared to adults without ADHD (1.4% and 0.6%, respectively; Kessler et al., 2006; 
Table 3). 
ADHD Among Adults with Substance Use Disorders. According to nationally 
representative data presented by Kessler et al. (2006), adults with substance use disorders 
have an elevated prevalence of ADHD. In fact, nearly three times as many adults with 
substance use disorders (10.8%) have ADHD compared to adults without substance use 
disorders (3.8%; Table 3). 
ADHD Among Adults With Alcohol Use. The prevalence of ADHD was more 
than double among individuals with alcohol abuse and alcohol dependence (9.5% and 
11.1%, respectively), compared to individuals without alcohol abuse and alcohol 
dependence (4.0% and 4.0%; Kessler et al., 2006; Table 3). 
ADHD Among Adults With Drug Use. The prevalence of ADHD was much 
higher for individuals with drug abuse and drug dependence (25.4% and 10.8%, 
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respectively), compared to individuals without drug abuse and drug dependence (4.0% 
and 3.8%, respectively; Kessler et al., 2006; Table 3). 
Table 3: Comorbidity of Adult ADHD With Substance Use Disorders (2006) 
Prevalence of ADHD Prevalence of Substance Use 
(%)^ Disorders 
(%)!  
Among Among Among Among 
Respondents Respondents Respondents Respondents 
With Substance Without Substance With ADHD Without ADHD 
 Use Disorders Use Disorders  
Substance Use 
Disorders 











Adapted From: Kessler et al., 2006. 
^ - These numbers can be interpreted as, for example, 9.5% of individuals with alcohol abuse have ADHD 
and 4% of those without alcohol abuse have ADHD. 
- These numbers can be interpreted as, for example, 5.9% of individuals with ADHD have alcohol abuse 
and 2.4% of those wihout ADHD have alcohol abuse. 
Conclusion 
The epidemiological data reported in this section provides answers to many 
questions related to ADHD, smoking and substance abuse. The prevalence of ADHD is 
higher among children than adults, and is higher among males than females at all ages. 
Overall, Thunder Bay has the highest rate of smoking, followed by the United States, 
25.4 4.0 4.4 0.6 
10.8 3.8 15.2 5.6 
11.1 4.0 5.8 2.0 
2.4 
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Ontario, and Canada. Also, a higher percentage of males smoke than females in the 
United States, Canada, and Ontario, although a higher percentage of females smoke than 
males in Thunder Bay. Furthermore, smoking rates are highest for young adults and 
lowest for older adults among all four populations. While there were no studies that 
examine the prevalence of ADHD among smoking populations, it was noted that the 
prevalence of smoking among ADHD populations is very high - especially among adults. 
Alcohol dependence and drug dependence are the major forms of substance abuse 
for the United States, Canada, and Ontario. Despite the different forms of measurement 
used to gather substance abuse prevalence data, alcohol dependence was consistently 
three times higher among males than females in the United States, Canada, and Ontario. 
Drug use and dependence rates were also higher for males than females in Canada. In the 
United States, illicit drug use was highest for young adults and lowest for youth and 
middle to older age adults. 
Substance abuse was not found to be higher among children and adolescents with 
ADHD than children and adolescents without ADHD. However, an interesting finding 
was that the substance abuse rates were higher in this cohort when ADHD was combined 
with conduct disorder. For adults with ADHD, substance abuse was much more 
prevalent compared to adults without ADHD. 
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Section 2: Adult ADHD & Smoking: A Review of the Literature 
Introduction 
This section provides a summary of the existing studies related to ADHD and 
smoking, and the answers to a number of questions related to these studies. The 
questions covered in this section include: 1) What types of research have been conducted 
to explore questions related to ADHD and smoking? 2) What research questions have 
been explored relative to ADHD and smoking? 3) What populations have been studied 
and what ones are clearly lacking? 4) How was ADHD measured in the studies? 5) How 
was smoking measured in the studies? 6) What were the findings and what do they 
mean? 7) Why do people with ADHD smoke, and how do they differ from those who 
smoke but do not have ADHD? 8) What considerations are there when developing an 
intervention for smokers with adult ADHD? 9) What considerations should be made for 
the future of smoking and ADHD? 
Method 
A literature review was conducted to provide a summary of all the available 
studies relating adult ADHD and smoking. The review included a search of English 
databases - Pubmed, ERIC, and the Cochrane Library. The grey literature search 
included professional associations and government websites - Centers for Disease 
Control and Prevention, Health Canada, and Statistics Canada, as well as google.ca and 
scholar.google.ca. Keywords for the search included ADHD, adult ADHD, smoking, 
nicotine. Searching was limited to 1995 to 2007. Most research published prior to 1995 
would not be relevant to informing the current relationship between ADHD and smoking, 
but needed to go back to 1995 due to the dearth of literature in this area. Subject/MESH 
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headings or keywords, depending upon the database’s indexing system, were used to 
retrieve citations. 
Selections were thoughtfully chosen to include scholarly evidence from research 
studies, systematic reviews as well as descriptive articles and editorials that identified 
issues of concern. Most of the literature dates from the last 5-10 years. 
Results 
Research Question 1: Types of Research Related to ADHD and Smoking 
The literature search yielded 33 articles, several of which did not meet sufficient 
criteria for inclusion. Articles needed to include studies about smoking and ADHD. 
Many of the articles were in relation to ADHD and substance use/abuse, often grouping 
smoking into the category of substance use/abuse or neglecting smoking entirely. These 
types of studies were excluded from the search, yielding nine that met sufficient criteria 
for inclusion - five experimental studies (Conners et al., 1996; Gehricke et al., 2006; 
Lerman et al., 2001; Levin et al., 2001; and, Ohlmeier et al., 2007; Table 4; Table 5), 
three longitudinal studies (Kollins et al., 2005; Lambert and Hartsough, 1998; and, 
Wilens et al., 2007; Table 4; Table 5), and one cross-sectional study (Pomerleau et al., 
1995; Table 4, Table 5). 
The study by Conners et al. (1996) examined the effect of nicotine on adults with 
ADHD (n = 22). Gehricke et al. (2006) examined the effect of nicotine on particular 
symptoms of ADHD (n = 10). Lerman et al. (2001) examined the relationship between 
ADHD symptoms and smoking behaviour (n = 226). Levin et al. (2001) examined the 
effect of nicotine when used to treat adult ADHD (n = 40). Ohlmeier et al. (2007) 
examined the relationship between nicotine dependence and adult ADHD (n = 91). 
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The study by Kollins et al. (2005) examined ADHD symptoms in relation to 
smoking (n = 13,852); Lambert and Hartsough (1998) examined smoking rates among 
ADHD and non-ADHD adults (n = 400); and, Wilens et al. (2007) looked at whether or 
not individuals with ADHD use substances to self-medicate (n = 214). 
The cross-sectional study by Pomerleau et al. (1995) was the first study to look at 
smoking rates among adults with ADHD (n = 71; Table 4, Table 5). 
Research Question 2: Research Questions Related to ADHD and Smoking 
Many research questions have been explored related to ADHD and smoking. The 
research questions can be classified into four categories, including; smoking rates among 
adults with ADHD, smoking and ADHD symptoms, effects of nicotine, and the role of 
stimulant medication. Studies on smoking rates among adults with ADHD include the 
smoking rate, the smoking quit rate and the smoking intensity rate of individuals with 
adult ADHD, compared to the general population (Lambert & Hartsough, 1998; 
Pomerleau et al., 1995; Wilens et al., 2007). Studies on smoking and ADHD symptoms 
include the role smoking plays among inattention symptoms and hyperactivity and 
impulsivity symptoms related to adult ADHD (Kollins et al., 2005; Lerman et al., 2001). 
Studies on the effects of nicotine include nicotine dependence and the beneficial effects 
of nicotine among adults with ADHD (Conners et al., 1996; Levin et al., 2001; Ohlmeier 
et al., 2007). Studies of the role of stimulant medication explore whether or not stimulant 
medication can aid in tobacco cessation, can potentiate the effects of nicotine, can be 
administered safely, and can be considered the most effective treatment to aid in tobacco 
cessation among the adult ADHD population (Gehricke et al., 2006; Kollins et al., 2005; 
Wilens et al., 2007; Wilens et al., 2008). 
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Research Question 3: Populations Studied and Populations Lacking 
In the literature, the bulk of information regarding smoking and ADHD is targeted 
towards children, adolescents and young adults (Kollins et ah, 2005; Lambert & 
Hartsough, 1998; Wilens et ah, 2007). Adult ADHD data are more difficult to find, 
especially when it particularly involves smoking/nicotine. In addition to a general lack of 
adult ADHD and smoking data in the literature, there is literally nothing for older adults 
(in the 55 or older range). Of the limited adult ADHD and smoking studies, many are 
longitudinal in type, focus on males as opposed to females, reflect populations from the 
United States and build on previous work of ADD/ADHD children studied previously 
(Kollins et al., 2005; Lambert & Hartsough, 1998; Wilens et ah, 2007). 
Research Question 4: How ADHD is Measured in the Studies 
In the ADHD and smoking studies, ADHD was measured using three ADHD 
scales, including the Wender Utah Rating Scale (61 items, 5-point scale; Wender, 1995), 
the Connors/Wells Adolescent/Adult Self-Report Scale (87 items, 4-point scale; Conners 
& Wells, 1985), and the Conners Adult ADHD Rating Scale (30 items, 4-point scale; 
Conners et al., 1999; Table 5). Some studies used more than one measure to assess 
ADHD. Also, ADHD was measured differently among the experimental/RCT studies 
(Conners et al., 1996; Gehricke et al., 2006; Lerman et al., 2001; Levin et al., 2001; and, 
Ohlmeier et al., 2007; Table 4; Table 5), the longitudinal studies (Kollins et al., 2005; 
Lambert and Hartsough, 1998; and, Wilens et al., 2007; Table 4; Table 5), and the cross- 
sectional study (Pomerleau et al., 1995; Table 4, Table 5). 
Meausrement of ADHD in Experimental/RCT Studies. ADHD was primarily 
measured using adult ADHD self-report scales for the experimental/RCT studies (Table 
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5). The Wender Utah Rating Scale was used in three of the five experimental/RCT 
studies to measure ADHD (Conners et ah, 1996; Gehricke et ak, 2006; Levin et al., 
2001). The Connors/Wells Adolescent/Adult Self-Report Scale was used in both 
Conners et al. (1996), and Levin et al. (2001), and the Connors Adult ADHD Rating 
Scale (long version) was used by Ohlmeier et al. (2007). 
In addition to the adult ADHD self-report scales, the experimental and RCT 
studies used other methods to measure ADHD among study participants (Table 5). 
Barkley’s Adult ADHD Semi-Structured Interview was used by Conners et al. (1996) in 
addition to using self-report scales. Also, self-report questions on a four-point Likert 
scale were used by Lerman et al. (2001), in order to explore ADHD symptoms among 
smoking behaviour. 
Measurement of ADHD in Longitudinal Studies. ADHD was measured in three 
unique ways for the longitudinal studies (Table 5). Kollins et al. (2005) had participants 
retrospectively report two categories of ADHD symptoms (hyperactivity/impulsivity and 
inattention) from childhood on a Likert scale. Based on the answers to the questions, the 
researchers assessed the severity of ADHD. 
The study by Lambert and Hartsough (1998), measured ADHD in a fashion 
unique to the other studies (Table 5). Since the original sample was measured in 1974, 
Lambert and Hartsough (1998) used the Children’s Attention and Adjustment Survey 
(CAAS). The behaviour of the participants in the survey actually helped develop the 
DSM-III guidelines for ADHD, as the criteria for ADHD were still evolving at the time 
(Lambert & Hartsough, 1998). 
Wilens et al. (2007) measured ADHD in three stages of assessment (Table 5): 
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1) initial referral to a clinic for ADHD diagnosis as children; 2) supplemental 
confirmation of ADHD via telephone questionnaire; and, 3) final clinical interview for 
DSM-IV ADHD for participants aged 18 and older. 
Measurement of ADHD in the Cross-Sectional Study. The semi-structured 
interview by Pomerleau et al. (1995) measured adult ADHD by means of a behaviour 
checklist regarding the presence of DSM-III ADHD symptoms (Table 5). 
Research Question 5: How Smoking is Measured in the Studies 
In the ADHD and smoking studies, smoking was measured using the Fagerstrom 
Test for Nicotine Dependence (Kollins et ah, 2005; Pomerleau et al., 1995; Ohlmeier et 
al., 2007) and a variety of study-specific measures that often included smoking history 
and smoking habits. Smoking was measured differently among the experimental/RCT 
studies, the longitudinal studies, and the semi-structured interview study. 
Measurement of Smoking in Experimental/RCT Studies. There were five 
experimental/RCT studies included in the adult ADHD and smoking section (Table 5). 
One of the studies did not include any smokers at all. Of the other four 
experimental/RCT studies, all included some aspect of smoking history and smoking 
habits (Table 5). Both Conners et al. (1996) and Ohlmeier et al. (2007) used the 
Fagerstrom Test for Nicotine Dependence. The Fagerstrom Test for Nicotine 
Dependence is a self-report scale that measures an individuals’ dependence level on 
nicotine in addition to the amount an individual smokes (Heatherton, 1991). 
Gehricke et al. (2006) assessed smoking history and smoking habits by self-report 
measures developed specifically for their study (Table 5). Lerman et al. (2001) 
developed smoking measures as well, focusing on four smoking categories, including: 
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smoking history (i.e., smoking initiation and daily use), smoking motives, smoking urges 
and nicotine dependence. 
Measurement of Smoking in Longitudinal Studies. The longitudinal studies 
explored a great deal of self-report smoking measures tailored specifically towards the 
nature of the study (Table 5). Kollins et al. (2005) examined a number of measures 
related to smoking history, including: 1) having ever tried smoking; 2) having taken only 
1 or 2 puffs but having never smoked an entire cigarette; 3) number of cigarettes smoked 
over the last 30 days; and, 4) age of onset of regular smoking. 
Lambert and Hartsough (1998) looked at participants’ use of tobacco as adults, as 
well as their attitudes and opinions regarding smoking, using the California Smoking 
Baseline Survey (CSBS) and the Quick Diagnostic Interview Schedule (Table 5). Wilens 
et al. (2007) used the Drug Use Screening Inventory to explore frequency of tobacco use 
over the last month, motivation for initiation and continued use, and problems associated 
with use. 
Measurement of Smoking in the Cross-Sectional Study. Pomerleau et al. (1995) 
measured smoking using the Fagerstrom Tolerance Questionnaire (Fagerstrom, 1978). 
The Fagerstrom Tolerance Questionnaire was the precursor to the Fagerstrom Test for 
Nicotine Dependence (Heatherton, 1991). 
Research Question 6: Findings and Meaning of Findings 
Smoking Rates Among Adults with ADHD. The smoking rate is higher in adults 
with ADHD compared to those without ADHD (Lambert & Hartsough, 1998; Pomerleau 
et al., 1995; Table 4). This finding was initially noted by Pomerleau et al. (1995) who 
reported that 42% of ADHD males and 38% of ADHD females were current smokers. 
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compared to non-ADHD males and females (28.1% and 23.5%, respectively). A similar 
finding was later reported by Lambert and Hartsough (1998), who stated that the 
proportion of participants with ADHD who are current smokers (42%) continues to 
exceed that of the age-mate controls (26%). Furthermore, adults with ADHD have a 
greater proportion of daily smokers and smoke at a greater intensity than adults without 
ADHD (Lambert & Hartsough, 1998; Wilens et al., 2007; Table 4). Lambert and 
Hartsough (1998) found that the rates of daily smoking among the adult smokers was 
35% for the participants with ADHD in contrast to 16% for the age-mate controls. Also, 
Wilens et al. (2007) reported twice as much heavy cigarette use among adults with 
ADHD (47%) eompared to adults without ADHD (21%). Heavy cigarette use included 
participants who engaged in smoking more than 20 times in the past 30 days according to 
the Drug Use Sereening Inventory (DUSI; Wilens et al., 2007). 
Smoking Cessation Among Adults with ADHD. Adults with ADHD have a more 
difficult time quitting smoking than adults without ADHD (Pomerleau et al., 1995; Table 
4). Pomerleau et al. (1995) reported a 29% quit ratio in their sample, compared to a 
48.5% quit ratio in the general population. The relatively high eessation rates may be 
attributed to the low sample size (n = 71) of the semi-structured interview study by 
Pomerleau et al. (1995). 
Smoking and ADHD Symptoms. It is unclear exactly what ADHD symptoms are 
associated with smoking (Kollins et al., 2005; Lerman et al., 2001; Table 4). The 
literature provides conflicting findings between smoking and a) hyperactivity/impulsivity 
symptoms, and b) inattention symptoms, of adult ADHD. Lerman et al. (2001) reported 
that smoking is associated with inattention symptoms and not hyperactivity/impulsivity 
Adult ADHD & Smoking in NW Ontario 40 
symptoms of adult ADHD. In fact, the participants may be using the nicotine to help 
self-medicate the inattention symptoms of adult ADHD (Lerman et ah, 2001). In 
contrast, Kollins et al. (2005) suggest that smoking is associated with 
hyperactivity/impulsivity symptoms, stating that the hyperactivity/impulsivity symptoms 
were found to be a better predictor of lifetime regular smoking than inattention 
symptoms. The documented debate in the literature suggests a need to further explore the 
relationship between smoking and ADHD symptoms. 
Effects of Nicotine on Adults with ADHD. Nicotine dependence is significantly 
higher in adults with ADHD than the rest of the population (Ohlmeier et al., 2007; Table 
4). According to Ohlmeier et al. (2007), 76.2% of adult ADHD patients had ‘average to 
high’ nicotine dependence compared to patients without adult ADHD (45.7%). 
Adults with ADHD tend to smoke due to the beneficial effects involved with 
nicotine (Conners et al., 1996; Levin et al., 2001; Table 4). Conners et al. (1996) 
reported a number of positive effects associated with the use of nicotine on adults with 
ADHD. The most notable findings were that nicotine improved self-rated vigor, 
improved coneentration, and improved performance on measures of attention and timing 
accuracy among adult with ADHD (Conners et al., 1996). Similarly, Levin et al. (2001) 
reported that acute nicotine significantly reduced the severity of clinical symptoms of 
ADHD. These results indicate that nicotine provides some relief for many adults with 
ADHD, and suggest that nicotine may be used as a form of self-medication. 
Role of Stimulant Medication for Adults with ADHD. Stimulant medication has 
been shown to aid in tobacco cessation for individuals with adult ADHD (Gehrieke et al., 
2006; Table 4). In fact, Gehrieke et al. (2006) suggest that smokers may be able to 
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significantly reduce their nicotine intake by taking stimulant medication. However, 
stimulant medication has not proven as effeetive at treating symptoms of ADHD as 
nieotine, among adults with ADHD (Gehricke et al., 2006). Gehrieke et al. (2006) 
suggest that administering higher doses of stimulant medieation might equal the 
treatment effects of nicotine among adults with ADHD. 
There is an underlying risk that stimulant medication can become addictive when 
used to treat ADHD (Kollins, 2007). In a review of medications used to treat adult 
ADHD by Kollins (2007), it was reported that stimulant drugs exhibit the potential for 
abuse. Another recent study reported similar findings to Kollins (2007) regarding the 
abuse potential of stimulant drugs. Wilens et al. (2008) reported that despite the well- 
documented safety profile of the stimulants used in the treatment of ADHD, consistent 
evidence of misuse of stimulants in older adoleseents and young adults exists. Although 
the potential abuse of stimulant medications continues to be highly debated in the 
literature, it is important to consider the findings by Kollins (2007) and Wilens et al. 
(2007), when developing interventions for adults with ADHD. 
There does not appear to be a more effective treatment than stimulant medieation 
to aid in tobacco cessation among the adult ADHD population at the moment. While 
there has been more widespread use of non-stimulant drugs for treating ADHD in 
ehildren, the effectiveness of these drugs is still relatively unknown, and requires further 
testing (Kollins, 2007). Preliminary results have shown that non-stimulant drugs used to 
treat ADHD have not demonstrated signifieant abuse potential (Kollins, 2007). 
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Research Question 7: Difference Between Smokers and Non-Smokers with Adult ADHD 
Why People with ADHD Smoke. The studies related to adult ADHD and smoking 
indicate that adults with ADHD smoke at a greater rate, and have a more difficult time 
quitting smoking, than adults without ADHD (Lambert & Hartsough, 1998; Pomerleau et 
ah, 1995; Wilens et ah, 2007). While it is still uncertain exactly which types of ADHD 
symptoms the increased smoking is associated with, it is clear that smoking helps to 
alleviate at least some of these symptoms in adults (Kollins et ah, 2005; Lerman et ak, 
2001). In particular, the nicotine from cigarettes has been shown to provide several 
beneficial effects to adults with ADHD that, to this point, have not been equaled by any 
other treatment (Gehricke et ah, 2006). 
Key Difference Between ADHD Smokers and Non-ADHD Smokers. The adult 
ADHD and smoking studies suggest that the key difference between adults with ADHD 
who smoke and adults without ADHD who smoke is nicotine dependence (Ohlmeier et 
al., 2007). Adults with ADHD are generally undiagnosed, having to cope with a number 
of ADHD symptoms in their day-to-day lives. Many of these individuals develop a 
dependence on nicotine as it is an effective, and quite possibly, the only means to help 
alleviate the symptoms of ADHD. Adults without ADHD do not have clinically 
disabling symptoms related to inattention and hyperactivity/impulsivity, and thus, do not 
develop nicotine dependence at the same rate as adults with ADHD. 
Research Question 8: Intervention Considerations for Adult Smokers with ADHD 
The adult ADHD and smoking studies touch on a number of important issues to 
consider when developing an intervention for smokers with adult ADHD. Initially, 
individuals developing an intervention need to understand the differences between a 
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smoker with ADHD and a smoker without ADHD. Smokers with ADHD are generally 
much more dependent on nicotine than individuals without ADHD (Ohlmeier et ah, 
2007). Nicotine helps smokers with ADHD to cope with ADHD symptoms (Conners et 
ah, 1996; Levin et al., 2001), and may also be the only coping mechanism available to 
smokers with ADHD. These findings suggest that nicotine replacement therapy might be 
really important in helping smokers with adult ADHD to quit. 
Another consideration is deciding on a safe, effective treatment to help cope with 
ADHD symptoms. While Gehricke et al. (2006) have suggested many benefits 
associated with stimulant treatment, other researchers such as Kollins et al. (2007) and 
Wilens et al. (2008), have reported the underlying risks associated with stimulant 
medications. Adults with ADHD are individual people, with different backgrounds and 
potential contraindications. It is important to consider the particular characteristics of the 
individual when developing interventions and exercise caution when prescribing 
medications to potential high-risk groups. Also, individuals developing an intervention 
should provide as much information as possible regarding the abuse potential of 
medications. Otherwise, potential patients may be reluctant to initiate an effective 
treatment. 
Research Question 9: Future Considerations for Smoking and ADHD 
The adult ADHD and smoking studies suggest that further research is necessary to 
determine a safe, effective alternative to cigarette smoking for treating adult ADHD 
(Kollins et al., 2007; Wilens et al., 2008). At the moment, stimulant therapy and nicotine 
replacement therapy appear to be effective treatments for adult ADHD, although the risks 
associated with each type of treatment continue to be debated in the literature (Gehricke 
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et al., 2006; Kollins et al., 2007; Wilens et al., 2008). There is a continued need to 
further explore stimulant therapy, nicotine therapy, and other types of therapy among the 
adult ADHD population. 
Conclusion 
The studies indicate that adults with ADHD have a greater prevalence of smoking 
and a harder time quitting smoking than adults without ADHD. While it is unclear 
exactly which types of ADHD symptoms that smoking is associated with, it is clear that 
the nicotine from cigarettes provides beneficial effects to adults who suffer from ADHD. 
These beneficial effects lead to the key difference between adults with ADHD who 
smoke and adults without ADHD who smoke: nicotine dependence. 
There are important intervention considerations for adult smokers with ADHD. 
In addition to the difference in nicotine dependence for adult smokers with ADHD 
compared to adult smokers without ADHD, it is important to consider a treatment that is 
both effective and safe for the unique individual suffering from ADHD. In order to 
accomplish this, there is a need for more research into stimulant therapy, nicotine 
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Section 3: Paving the Way for Research in ADHD and Smoking in NW Ontario 
Introduction 
This section covers three questions related to adult ADHD: 1) What are the 
similarities, differences, psychometric properties, and criticisms of adult ADHD rating 
scales? 2) What are the particular considerations of an adult ADHD and smoking study, 
including smoking history and habits, smoking motivation, history of stimulant 
medications, and history of substance use and abuse? and, 3) What considerations are 
there for both a stimulant drug study and an adult ADHD study in Northwestern Ontario? 
Method 
A literature review was conducted to provide a summary of the available rating 
scales and screening tools that exist to measure adult ADHD. The review included a 
search of English databases - Pubmed, ERIC, and the Cochrane Library. The grey 
literature search included professional associations and government websites - Health 
Canada and Statistics Canada, as well as google.ca and scholar.google.ca. Keywords for 
the search included ADHD, adult ADHD, rating scale, screening tool, psychometric 
property, validity, and reliability. Searching was limited to 1991 to 2008. Most research 
published prior to 1991 would not be relevant to adult ADHD rating scales, but needed to 
go back to 1991 due to the dearth of literature in this area. Subject/MESH headings or 
keywords, depending upon the database’s indexing system, were used to retrieve 
citations. 
Selections were chosen - based on their use in recent adult ADHD research - to 
include scholarly evidence from research studies, systematic reviews as well as 
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descriptive articles and editorials that identified issues of concern. Most of the literature 
dates from the last 5-10 years. 
Results 
Research Question 1: Characteristics of Adult ADHD Rating Scales 
There are a number of different screening tools and rating scales that currently 
exist to measure adult ADHD. These scales include: Wender Utah Rating Scale 
(WURS; Ward et al., 1993); Conners’ Adult ADHD Rating Scale (CAARS; Conners et 
al., 1999); Brown Attention-Deficit Disorder Rating Scale (BADDS) for Adults (Brown, 
1996); Copeland Symptom Checklist for Adult ADHD (Copeland, 1991); WHO Adult 
ADHD Self-Report Scale (ASRS) - Version 1.1 (Kessler et al., 2005); and. Adult Self- 
Report Scale (ASRS) Screener (Kessler et al., 2005; Table 6). 
Similarities and Differences of Adult ADHD Scales. The adult ADHD 
tools/scales were generally quite different from one another aside from using self-report 
administration and having a rating scale format (Table 6). The number of items vary 
from six (ASRS Screener) to 63 (Copeland Symptom Checklist). Similarly, the scales 
differ in estimated completion time, with a range of two minutes (ASRS Screener) to 20 
minutes (Copeland Symptom Checklist, WURS). The format displayed some variation 
as well, consisting of 3, 4, and 5-point Likert scales that were frequency-based (Kooij et 
al., 2008; Table 6), severity-based (McCann et al., 2000; Copeland 1991; Kessler et al., 
2005; Table 6) or both frequency & severity-based (Bowes, 2001; Table 6). 
Psychometric Properties of Adult ADHD Scales. The literature related to the 
psychometric properties of adult ADHD scales was rather limited. Since the scales are 
relatively new in the literature, it was anticipated that validity and reliability information 
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would be difficult to find. Despite the difficulty experienced in the search for properties, 
psychometric evidence was obtained for each of the rating scales aside from the 
Copeland Symptom Checklist for Adult ADHD. The psychometric evidence was verified 
by clinically diagnosing the study participants after each scale was utilized. The adult 
ADHD clinical diagnosis results were subsequently compared to the ADHD scale results 
to determine the psychometric properties. 
The psychometric properties were derived from a variety of studies and were 
operationalized when necessary to fit as either “sensitivity” or “specificity” (Table 6). 
The term “sensitivity” referred to how often the particular rating scale correctly identified 
the individuals with adult ADHD as having the disorder (expressed as a percentage), 
while the term “specificity” referred to how often the particular rating scale correctly 
identified the individuals without adult ADHD as not having the disorder (expressed as a 
percentage). 
The Wender Utah Rating Scale (WURS) properties were reported by McCann et 
al. (2000; Table 6). The classification procedure correctly classified 64.5% of ADHD 
patients (sensitivity). Among those who did not have ADHD, only 57.5% were correctly 
classified (specificity; McCann et al., 2000). 
The Conners’ Adult ADHD Rating Scales (CAARS) properties were reported by 
Bowes (2001; Table 6). The CAARS produced a false-positive rate of about 13% (87% 
sensitivity) and a false-negative rate of 18% (82% specificity; Bowes, 2001). 
The properties of the Brown Attention-Deficit Disorder Rating Scale (BADDS) 
for Adults were reported by Kooij et al. (2008; Table 6). Using a total score of 50 or 
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more on the BAADS, 84% were correctly diagnosed with adult ADHD (sensitivity; Kooij 
et ah, 2008). 
The WHO Adult ASRS - Version 1.1 properties and the ASRS Screener 
properties were both reported by Kessler et al. (2005; Table 6). According to this study, 
the unweighted six-question ASRS screener outperformed the unweighted 18-question 
ASRS in sensitivity (68.7% v. 56.3%, respectively) and specificity (99.5% v. 98.3%, 
respectively; Kessler et al., 2005). 
Criticisms of Adult ADHD Scales. According to Kooij et al. (2008), the validity 
and accuracy of self-report information about symptoms of ADHD in adults have been 
considered questionable because they depend on the recall of childhood symptoms. 
Often this can lead to recall bias. Moreover, adolescents and adults with ADHD 
generally have problems with self-reflection and self-evaluation, and this may well lead 
to under-reporting (Kooij et al., 2008). 
Another criticism of adult ADHD scales is that they cannot be used as stand-alone 
agents for diagnosis. According to one study, physicians also need to ask key questions 
about the patient’s past and current impairment, take medical, educational, social, 
psychological, and vocational histories, and rule out other conditions before concluding 
that ADHD is the appropriate diagnosis (Murphy & Adler, 2004). While self-reporting 
scales/screening tools are a helpful starting point, they cannot replace an extensive 
clinical history and knowing when to refer the patient to a healthcare professional with 
adult ADHD expertise (Kessler et al., 2005). 
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Research Question 2: Considerations of an Adult ADHD and Smoking Study 
There are a number of items to eonsider in a study of adult ADHD and smoking to 
elueidate why people smoke and to clarify what they might need in order to quit. Based 
on the adult ADHD and smoking studies reviewed, there are clear smoking topics to 
focus on in future studies, including: smoking history and habits, smoking motivation, 
history of stimulant medications, and history of substance use and abuse. 
Smoking Initiation. The relationship between ADHD symptoms and smoking is 
linear, with a greater number of ADHD symptoms associated with earlier regular 
smoking (Kollins et al., 2005). In order to help an adult with ADHD quit smoking, it is 
important to record their smoking history as it may help to predict the strength of the 
relationship between ADHD and smoking (Kollins et al., 2005). 
Smoking Habits. The Fagerstrom Test for Nicotine Dependence measures 
smoking habits to determine an individual’s level of nicotine dependence (Heatherton, 
1991). In addition to assessing the level of dependence on nicotine, the Fagerstrom Test 
for Nicotine Dependence addresses the amount and frequency of cigarette smoking 
(Heatherton, 1991). Clearly, the Fagerstrom Test for Nicotine Dependence should be 
included in any study looking at adult ADHD and smoking. 
Quit Attempts. Another important aspect to consider is the history of quit 
attempts, as adults with ADHD have a more difficult time quitting smoking than adults 
without ADHD (Pomerleau et al., 1995). The questions related to quit attempts should 
focus on the number of quit attempts, success of previous quit attempts, use of nicotine 
replacement therapy (NRT), and withdrawal symptoms of previous quit attempts 
(Pomerleau et al., 1995). 
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Smoking Motivation. In addition to looking at the history and the habits of an 
individual smoker, it is also important to explore the reasons why an individual smokes. 
The best way to explore smoking motivation is to develop a “why do you smoke” 
questionnaire tailored specifically towards adults with ADHD (Herman et ah, 2001). The 
questionnaire should explore smoking as a form of self-medication and include questions 
related to specific inattention and hyperactivity/impulsivity symptoms of adult ADHD 
(Kollins et al., 2005). 
History of Stimulant Medications. There are many risks associated with stimulant 
medication use, especially among individuals with ADHD (Kollins et al., 2007; Wilens et 
al., 2008). However, stimulant medication use has been shown to be effective for treating 
ADHD symptoms for certain individuals (Gehricke et al., 2006). It is important to obtain 
knowledge about an individual’s history of stimulant medication use, as adequate 
information will help in the development of an appropriate cessation strategy that either 
includes, or does not include, stimulant therapy. 
History of Substance Use and Abuse. According to Kessler et al. (2006), nearly 
three times as many adults with ADHD have a substance use disorder compared to adults 
without ADHD. Gathering information about substance use and abuse from childhood 
onward may help to explain the mechanism of the relationship between substance use 
disorders and ADHD. 
Research Question 3: Considerations for a Drug Study and Adult ADHD Study in NW 
Ontario 
Stimulant Drug Study in NW Ontario. It is not worthwhile to consider a stimulant 
drug study for Northwestern Ontario at this point in time. Currently, there is far too 
much that is unknown about adult ADHD in Northwestern Ontario. While a stimulant 
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drug study may be beneficial to help solve the problem of adult ADHD in NW Ontario, it 
is first necessary to fully comprehend the magnitude of this problem. 
Adult ADHD Study in NW Ontario. The rates of smoking among adults are higher 
in Northwestern Ontario than the United States, Canada, and Ontario (Health Canada, 
2007; Statistics Canada, 2005). Also, adults with ADHD tend to smoke at a higher rate 
than adults without ADHD (Lambert & Hartsough, 1998; Pomerleau et al., 1995). Based 
on these two findings, it seems reasonable to assume that the prevalence of adult ADHD 
in Northwestern Ontario may be higher than the United States, Canada, and Ontario. 
However, at this point in time, no research has been done to explore the prevalence of 
adult ADHD in Northwestern Ontario. The lack of research is a concern, considering the 
4.4% estimate of adult ADHD in the United States (Kessler et al., 2006). The relatively 
conservative estimate of 4.4% by Kessler et al. (2006) may very well be much higher in 
Northwestern Ontario. There is a definite need to conduct a population-based survey in 
Northwestern Ontario to establish baseline rates of adult ADHD. Once the rates of adult 
ADHD have been established, researchers can begin to focus on other unique issues that 
face adults with ADHD in Northwestern Ontario, such as the elevated prevalence of 
smoking in the region. 
Conclusion 
While the adult ADHD rating scales/screening tools are a quick, relatively 
effective way to screen for adult ADHD, some research suggest that they cannot replace 
an extensive clinical history and the diagnoses of a qualified healthcare professional. 
For Northwestern Ontario, the prevalence of adult ADHD is unknown and, 
considering the elevated rates of smoking in Northwestern Ontario, there is reason to 
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believe that the ADHD rate might exeeed the conservative estimate in the literature. 
Future research on adult ADHD in Northwestern Ontario should focus on establishing an 
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